Efficacy of F-18-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computerized Tomography for Bone Marrow Infiltration Assessment in the Initial Staging of Lymphoma

Creative Commons License

Oner A. O., Budak E., AYDIN F., SALİM O., YÜCEL O. K., AKKAYA B., ...More

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.26, no.2, pp.69-75, 2017 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.4274/mirt.54376
  • Journal Name: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.69-75
  • Keywords: Hodgkin's lymphoma, non-Hodgkin's lymphoma, positron emission tomography/computerized tomography, bone marrow biopsy, NON-HODGKINS-LYMPHOMA, F-18-FDG PET/CT, AGGRESSIVE LYMPHOMA, MALIGNANT-LYMPHOMA, CELL LYMPHOMA, FDG-PET/CT, INVOLVEMENT, BIOPSY, DISEASE, MANAGEMENT
  • Open Archive Collection: AVESIS Open Access Collection
  • Akdeniz University Affiliated: Yes

Abstract

Objective: Currently F-18-2-fluoro-2-deoxy-D-glucose (F-18-FDG) positron emission tomography/computerized tomography (PET/CT) is being successfully used for staging and follow-up of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). Various studies have demonstrated that PET/CT effectively detects bone marrow involvement (BMI) and is concordant with bone marrow biopsy (BMB) findings, thus it is deemed as a complementary method. This study was aimed to evaluate-F-18-FDG-PET/CT efficiency for detection of BMI in HL and NHL.